Page last updated: 2024-11-05

trihexyphenidyl and Bewilderment

trihexyphenidyl has been researched along with Bewilderment in 3 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Robinson, ML1
McEvoy, JP1
McCue, M1
Spring, B1
Mohs, RC1
Lavori, PW1
Farr, RM1
Martin, WE1
Loewenson, RB1
Resch, JA1
Baker, AB1

Trials

2 trials available for trihexyphenidyl and Bewilderment

ArticleYear
Effects of amantadine and trihexyphenidyl on memory in elderly normal volunteers.
    The American journal of psychiatry, 1987, Volume: 144, Issue:5

    Topics: Age Factors; Aged; Amantadine; Confusion; Dose-Response Relationship, Drug; Double-Blind Method; Fem

1987
A controlled study comparing trihexyphenidyl hydrochloride plus levodopa with placebo plus levodopa in patients with Parkinson's disease.
    Neurology, 1974, Volume: 24, Issue:10

    Topics: Affective Symptoms; Aged; Anxiety; Clinical Trials as Topic; Confusion; Drug Evaluation; Drug Therap

1974

Other Studies

1 other study available for trihexyphenidyl and Bewilderment

ArticleYear
Drug side effects and the double-blind design.
    The American journal of psychiatry, 1988, Volume: 145, Issue:4

    Topics: Amantadine; Confusion; Double-Blind Method; Humans; Memory Disorders; Research Design; Trihexyphenid

1988